Red Queen Bio

Red Queen Bio will rely on AI models as well as more traditional laboratory experiments to uncover new risks and develop new defenses. Red Queen Bio was spun out of Helix Nano, a clinical-stage mRNA therapeutics company that has been using AI more in drug design.

Health and bio

Red Queen Bio raised $15M in a Seed round announced November 13, 2025, according to reuters.com. Investors in that round: OpenAI Startup Fund.

Raise history

1. September 29, 2026
   First seen by Recent Funding
   via startups.gallery
2. November 13, 2025
   Seed · $15M
   OOpenAI Startup Fund (lead)
   Source: reuters.com (startups.gallery listing)

Investors

• OOpenAI Startup Fund

Related other companies

• QQuartermaster$140M · Sep 28, 2026
• SSnorkel AI$350M · Sep 23, 2026
• EEnveda$311M · Sep 23, 2026
• HHeidi Health$100M · Sep 22, 2026
• FFirecrawl$75M · Sep 22, 2026
• CCorridor$25M · Sep 21, 2026
• JJack & Jill$40M · Sep 19, 2026
• MMithr Inc.$20M · Sep 19, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/red-queen-bio.